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Cyclic lipo(depsi)peptides (CLiPs) from Pseudomonas constitute a class of natural
products involved in a broad range of biological functions for their producers. They
also display interesting antimicrobial potential including activity against Gram-positive
bacteria. Literature has indicated that these compounds can induce membrane
permeabilization, possibly through pore-formation, leading to the general view that the
cellular membrane constitutes the primary target in their mode of action. In support
of this view, we previously demonstrated that the enantiomer of pseudodesmin A,
a member of the viscosin group of CLiPs, shows identical activity against a test
panel of six Gram-positive bacterial strains. Here, a previously developed total organic
synthesis route is used and partly adapted to generate 20 novel pseudodesmin A
analogs in an effort to derive links between molecular constitution, structure and
activity. From these, the importance of a macrocycle closed by an ester bond
as well as a critical length of β-OH fatty acid chain capping the N-terminus is
conclusively demonstrated, providing further evidence for the importance of peptide-
membrane interactions in the mode of action. Moreover, an alanine scan is used
to unearth the contribution of specific amino acid residues to biological activity.
Subsequent interpretation in terms of a structural model describing the location and
orientation of pseudodesmin A in a membrane environment, allows first insight in
the peptide-membrane interactions involved. The biological screening also identified
residue positions that appear less sensitive to conservative modifications, allowing the
introduction of a non-perturbing tryptophan residue which will pave the way toward
biophysical studies using fluorescence spectroscopy.
Keywords: lipopeptides, bioactivity, alanine scan, structure-activity relationship, Pseudomonas, antimicrobial
activity, viscosin group
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INTRODUCTION
Antimicrobial resistance is eroding the utility of today’s
antibiotics and fuels the renewed drive to discover new antibiotics
(Bax et al., 1998; Fischbach and Walsh, 2009; Breidenstein et al.,
2011; Laxminarayan et al., 2013). Given the dearth of new
broad-spectrum antibiotics in the drug development pipeline,
focus has also expanded to the development of narrow-spectrum
or even species-specific antibiotics, allowing to create a much
more selective arsenal (Lewis, 2013). Antimicrobial peptides or
AMP’s have received wide-spread attention as a potential source
of such antibiotics (Lewies et al., 2019). The archetypal AMP
consists of a linear oligopeptide sequence bearing cationic and
hydrophobic residues with a sequence and spatial distribution
that generates amphipathic properties once properly folded
(Bradshaw, 2003; Jenssen et al., 2006; Huang et al., 2010;
Bahar and Ren, 2013). Such folding occurs as part of a variety
of modes of action whereby interaction with the bacterial
membrane perturbs the latter, ultimately causing lysis and killing
the bacteria. Many other classes of AMPs abound in Nature
do not fit this ‘archetype’ and appear less prominently in the
spotlight of antimicrobial research. Cyclic lipopeptides (CLiPs)
typically from Bacillus and Pseudomonas represent such an
alternative class of AMPs (Raaijmakers et al., 2010; Bionda et al.,
2013; Geudens and Martins, 2018; Götze and Stallforth, 2019).
With few exceptions, the common chemical blueprint of these
biosurfactants features an overall negative charge (as opposed
to positive), an N-terminal fatty acid chain (as opposed to its
absence) typically ten carbons long, while part of the oligopeptide
chain forms a macrocycle (as opposed to linear sequences) by
ester (depsi-) bond formation involving the C-terminus and
an alcohol functionality present in the structure (Figure 1A).
In contrast to well-known classes of AMPs, their biosynthesis
involves large multi-domain, non-ribosomal peptide synthetases
(Raaijmakers et al., 2010; Süssmuth and Mainz, 2017; Götze and
Stallforth, 2019), capable of introducing these features as well as
the presence of non-proteinogenic amino acids.
In addition to the antimicrobial potency of many of these
CLiPs, their broad functional role in a variety of biological
processes for their producers is well-established, as clearly lined
out in the seminal review of Raaijmakers et al. (2010) and
more recently reviewed for Pseudomonas CLiPs (Geudens and
Martins, 2018; Götze and Stallforth, 2019). Focusing on the latter,
Pseudomonas CLiPs (Ps-CLiPs) are involved in cell motility,
adhesion and biofilm formation (Alsohim et al., 2014; D’aes
et al., 2014; Song et al., 2014), but also have functions in
bacterial ecology as they promote plant-growth (D’aes et al.,
2010; Alsohim et al., 2014) or can trigger defense responses
in plants (Nielsen et al., 1999; D’aes et al., 2014). In addition
to antibiotic activity (Sinnaeve et al., 2009b; Jang et al., 2013),
antagonistic properties including antifungal (Gerard et al., 1997),
insecticidal (Groupe et al., 1951), antiviral (Van De Mortel et al.,
2009), and anti-oomycete activity have been established (Saini
et al., 2008) while more recently antitumor activity has also been
reported (Pascual et al., 2014; Cautain et al., 2015; Götze and
Stallforth, 2019). Thus, Ps-CLiPs appear as veritable biological
‘swiss-army knives’ (Geudens and Martins, 2018), a trait which
is increasingly recognized for AMPs in general (Haney et al.,
2019). In view of this, a clear potential exists for biomedical
and agricultural applications that invites further exploration
using a concerted approach involving structure determination,
biophysical investigation and biological evaluation of both
natural and synthetic analogs of a representative Ps-CLiP
(Geudens et al., 2018). Such an approach requires an efficient
(bio-)synthetic route for production of relevant analogs,
unavailable from Nature, whose biological evaluation of activity
can then be interpreted in terms of a three-dimensional
structure in a biologically relevant context. Here, we present
such a study for the viscosin group of Pseudomonas CliPs,
building on our previously reported total synthesis route for
pseudodesmin A (1, PsdA) (De Vleeschouwer et al., 2014)
and our recently obtained understanding of the structure
and dynamics of viscosinamide A at the lipid-water interface
using its investigation by NMR in a dodecylphosphatidylcholine
(DPC):water solution (Geudens et al., 2019).
With 17 characterized members, the viscosin group represents
the largest and most extensively characterized Ps-CLiP-group.
The ester (depsi) bond cyclizes these nonapeptides between the
C-terminus and the alcohol function of the D-allo-Thr (D-aThr)
sidechain at position 3, thus leading to a 7-residue macrocycle as
shown for PsdA (Figure 1A). The N-terminus is generally capped
by a 3-hydroxydecanoic acid (3-HDA) with R stereochemistry,
whenever explicitly reported. The sequence logo (Stephens, 1990)
of this group shows a conserved distribution of polar and
hydrophobic residues, with conservative substitutions for the
latter (Ile/Val) at position 4 and 9 (Figure 1B, original sequences
in Supplementary Material). The most notable variations occur
independently from each other and consist of a D-Glu/Gln
variation at position 2 and a D/L variation of stereochemistry
for Leu5. As a result, naturally occurring viscosin group CLiPs
can be subdivided in 4 groups (here labeled as L−, L0, D−, and
D0) depending on overall charge (0 or −1) and stereochemistry
(D or L).
We have previously reported the three-dimensional structure
of the 2 neutral subgroup representatives, viscosinamide A (D0)
(Geudens et al., 2014) and pseudodesmin A (L0) (Sinnaeve
et al., 2009a,b), while that of anionic WLIP (D−) was already
available from literature (Han et al., 1992). To avoid ambiguity,
the three-dimensional structure is referred to hereafter as the
‘fold’ of a Ps-CLiP whereas the chemical (covalent) structure will
simply be referred to as ‘structure’ as indicated in Figure 1C.
In spite of the D/L switch in stereochemistry for Leu5, all
have identical backbone folds, consisting of an N-terminal left-
handed α-helix spanning the first six residues, after which the
backbone folds back to close the macrocycle through ester bond
formation (Figure 1C). This fold organizes all side-chains such
that an amphipathic surface results (Figure 1D), with a neater
segregation of the polar and apolar surface for the D-subgroup
compared to the L-subgroup molecules (Figure 1D) (Geudens
et al., 2014). This amphipathic character is fully in line with the
current view (obtained from studies of individual Ps-CLiPs) that
the most likely mode of action involves direct interaction with the
cellular membrane, possibly through pore-formation (Coraiola
et al., 2006; Lo Cantore et al., 2006; Reder-Christ et al., 2012).
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FIGURE 1 | (A) Chemical structure of Pseudodesmin A (1) also used to illustrate the main aspects of the chemical blueprint of Pseudomonas cyclic
lipo(depsi)peptides: the ester bond forming the macrocycle (red) and the N-capping fatty acid chain (blue). (B) Sequence logo of Ps-CLiPs belonging to the viscosin
group including variations in fatty acid length of the 3-hydroxy-fatty acid moiety (C10 vs. C12) (see Supplementary Material for sequence listing). Stereochemistry
was not included as these are often made by inference or not available at all in the original literature. (C) Overall 3 days fold representing the solution structure of
pseudodesmin A in acetonitrile solution, the helix is indicated by a ribbon. (D) Solvent-accessible surface representation of Pseudodesmin A and Viscosinamide, with
green and red surfaces indicating hydrophobic and hydrophilic residues respectfully. Compared to the orientation in (C), the helix barrel is turned 90◦ to allow the
best presentation of the amphipathic character. In (C,D) the 3-OH decanoic acid chain is not shown beyond C3 as its flexibility precludes a definite orientation to be
determined.
We used fluorescence permeability assays involving model
membranes to show that the natural compounds (Geudens
et al., 2017), each representing an aforementioned viscosin
CLiP subgroup, induce permeabilization at µM concentration,
the neutral Ps-CLiPs pseudodesmin A (D0) and viscosinamide
A (L0) being somewhat more potent (C1/2 ∼3.7 µM) than
the charged ones WLIP and viscosin (C1/2 ∼4.9 µM). This
finding was found to be mostly in line with antibacterial
activity against a panel of Gram-positive pathogens (Geudens
et al., 2017). Finally, by developing a total chemical synthesis
route to viscosin group members, we demonstrated that the
biological activity of the enantiomer of PsdA (2) is identical
to the natural compound (1), apparently excluding a receptor
based interaction as the determining factor for biological activity
thus further substantiating the membrane as the primary target
(De Vleeschouwer et al., 2014).
To proceed toward full structure-activity studies, total
synthesis must be complemented by knowledge of the CLiP fold
within the lipid-water interface. To this end, we determined the
solution structure and the dynamics of viscosinamide (L0) in
a DPC-water mixture using NMR spectroscopy and Molecular
Dynamics simulations (Geudens et al., 2019). We showed that
the solution conformation previously available only from organic
solutions or in a crystal environment, is fully maintained in DPC
micelles. Paramagnetic relaxation enhancement measurements
allowed to locate individual viscosinamide molecules near
the water-lipid interface with an insertion depth and overall
orientation dictated by the amphipathic molecular properties.
Moreover, we established using NMR and 13C/15N labeled
viscosinamide that the hydrogen-bonding network is maintained
at the ms to s time scale, indicating a compact and rigid fold in
the lipid environment. With the availability of a suitable model
for the fold of viscosin group CLiPs in a biologically relevant
environment, the solid grounds required to interpret structure-
activity related information from a library of pseudodesmin A
analogs1 is now available, and is reported here, representing the
first such studies for Pseudomonas CLiPs.
MATERIALS AND METHODS
Synthesis, Purification, and
Characterization of PsdA Analogs
Chemicals and general procedures are listed in the
Supplementary Materials section. All procedures for the
synthesis and purification of specific building blocks as well
1Pseudodesmin A (L0) was initially used a lead compound to investigate structure
activity relationships, using the solution structure in acetonitrile as guide. Later
work demonstrated that in order to establish this solution structure in DPC
micelles, isotope labeled compound was an absolute requirement. Preference was
given to production of viscosinamide (D0), because of the high biosynthetic
performance of its bacterial producer (DR54), a trait required when producing
isotope labeled compounds from minimal media (Geudens et al., 2019). This
was not the case for the original Pseudodesmin A producer which is currently
unavailable due to third party patent protection issues.
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as solid-phase peptide synthesis, and cyclization release of the
PsdA-analogs were carried out as described previously for the
total synthesis of pseudodesmin A (1) and its enantiomer (2)
(De Vleeschouwer et al., 2014). Practical details and relevant
variations of the procedures for specific cases are collected in
the Supplementary Materials section of this paper, together
with full characterization of all fatty acid building blocks and
analogs. The crude cyclic lipopeptides were purified using either
semi-preparative or preparative RP-HPLC. Semi-preparative
purification was performed on an Agilent 1100 series instrument
using a Kromasil column (C18, 250 mm× 7.8 mm, 5 µm particle
size). The analyses were executed with a flow rate of 3 ml/min
and with the following solvent systems: H2O containing 0.1%
HCOOH (A) and CH3CN (B). Preparative purification was
performed on an Agilent 218 solvent delivery system with a
UV-VIS dual wavelength detector using a Phenomenex column
[AXIA packed Luna C18(2), 250 ∗ 21.2 mm, 5 µm particle size]
with a flow rate of 20 ml/min and following solvent systems:
H2O containing 0.1% TFA (A) and CH3CN (B). All LC-MS
data were collected with an Agilent 1100 Series HPLC with an
ESI detector type VL, equipped with a Kinetex column (C18,
150 mm × 4.60 mm, 5 µm particle size) with a flow rate of
1.5 ml/min. Two different gradients were used: (0–100) and
(75–100)%B in 6 min. NMR characterization of intermediates
and final building blocks was performed using 1H NMR and
13C NMR in CDCl3 on a Bruker Avance spectrometer equipped
with a 5 mm BBO probe and operating at 300 and 75.77 MHz,
respectively. High-resolution mass spectra were recorded on an
Agilent 6220A time-of-flight mass spectrometer, equipped with
an Agilent ESI/APCI multimode source. The ionization mode
was set to APCI (atmospheric pressure chemical ionization),
while the mass spectra were acquired in 4 GHz high-resolution
mode with a mass range set to 3200 Da.
NMR Characterization of the
PsdA-Analogs
Characterization was performed on a Bruker Avance III
spectrometer operating at a frequency of 500.13 and 125.76 MHz
for 1H and 13C, respectively, and equipped with a 5 mm 1H
BBI-Z probe. All NMR measurements on the final compounds
were performed on peptide solutions with 600 µl of CD3CN,
CDCl3 or dioxane-d8 (Eurisotop). High quality HP-7 (New Era
Enterprises Inc.) NMR tubes were used. Sample temperature
was set to 25◦C throughout. 2D spectra measured for structure
confirmation include 1H-1H TOCSY with a 90 ms MLEV-
17 spinlock, sensitivity-improved, multiplicity edited, 1H-13C
gHSQC using adiabatic 180◦ pulses, 1H -1H NOESY with a
300 ms mixing time and 1H-13C gHMBC experiments optimized
for a nJCH coupling of 8 Hz. Standard pulse sequences as present
in the Bruker library were used throughout. Typically, 2048 data
points were sampled in the direct dimension for 512 data points
in the indirect one, with the spectral width, respectively, set to
12 ppm along the 1H dimension and 110 ppm (gHSQC) or
220 ppm (gHMBC) along the 13C dimension. For 2D processing,
the spectra were zero filled to obtain a 2048 × 2048 real data
matrix. Before Fourier transformation, all spectra were multiplied
with a squared cosine bell function in both dimensions except for
the gHMBC where a squared sine bell was applied together with
magnitude calculation to address phase twisted lineshapes. The
complete assignments and spectral fingerprints are available as
Supplementary Material.
Biological Activity Assays
Antimicrobial activity of all compounds in Table 1 was tested
against Clostridium perfringens NCTC 8798, Enterococcus faecalis
LMG 8222, Enterococcus faecium LMG 9431, Staphylococcus
aureus LMG 10147, Streptococcus pneumoniae LMG 21598,
and Streptococcus pyogenes LMG 15868, with those of 1, 2,
11, 24, and 25 already reported before in the literature (De
Vleeschouwer et al., 2014, 2016, 2017). Strains with LMG
designation were obtained from the BCCM/LMG Bacteria
Collection (Ghent, Belgium) while strain NCTC 8798 was
obtained from the National Collection of Type Cultures (HPA,
London, United Kingdom). All strains were grown aerobically
at 37◦C on Brain Heart Infusion (Oxoid, Erembodegem,
Belgium), with the exception of C. perfringens NCTC 9789
which was grown aerobically at 37◦C on Reinforced Clostridial
Medium (Oxoid). Vancomycin (Sigma-Aldrich, St. Louis, MO,
United States) and daptomycin (SelleckChem, Boston, MA,
United States) were included as reference antibiotics to monitor
performance of the assay involving the broth micro-dilution
method (Clinical and laboratory standards Institute [CLSI],
2012). The minimal inhibitory concentration that inhibited
growth by at least 50% (MIC1/2) compared to the untreated
control was used as a measure of activity. MIC1/2s were
determined using flat-bottomed 96-well microtiter plates (TPP,
Trasadingen, Switzerland). The quantity of CLIP used for
biological assays were determined from solutions in CD3CN
using the digital ERETIC method as available in Topspin 3,
based on PULCON (Wider and Dreier, 2006). When insoluble
in CD3CN, CDCl3 was used instead. Following solvent removal,
stock solutions were of were obtained by adding appropriate
amounts of DMSO. Concentrations of CLIPs and antibiotics
tested ranged from 0.016 to 32 µg/ml. The inoculum was
standardized at approximately 5 × 105 colony forming units/ml.
The plates were incubated at 37◦C for 24 h and the optical
density was determined at 590 nm using a multi-label microtiter
plate reader (Envision Xcite, PerkinElmer LAS, Waltham, MA,
United States). In accordance with CLSI guidelines, MIC1/2
values were considered identical if they did not differ more than
one twofold dilution (Clinical and laboratory standards Institute
[CLSI], 2012).
RESULTS
Library Set Up and Synthesis of the PsdA
Analogs
The library of 20 PsdA analogs 3–21 and 23 collected in Table 1
is summarized in Figure 2. It was designed to (1) address
the possible importance of individual amino acids by using an
alanine scan of the sequence, except for the D-aThr3 required
for cyclization (3–10), two additional analogs (11–12) inspired
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TABLE 1 | Biological activity of Pseudodesmin A (1) and a series of synthetic analogs against a test panel of organisms, used to judge the importance of specific molecular determinants for overall activity.
Values and heat mapa presentation of absolute activity (MIC1/2) in µg/mL Relative activity factor distribution countb
# Name E. faecalis E. faecium S. aureus C. perfringens S. pneumoniae S. pyogenes 0.5≤F≤2 ×4 ×8 ≥16
LMG 8222 LMG 9431 LMG 10147 NCTC 8798 LMG 21598 LMG 15868
1 PsdAd 4 4 4 2 2 1 Reference
2 ent-PsdAd 8 4 2 4 2 2 6 0 0 0
Alanine Scan
3 PsdA- L1A 32 16 16 8 8 8 0 4 2 0
4 PsdA-Q2A >32 >32 >32 16 1 2 2 0 1 3
5 PsdA-V4A >32 32 8 16 8 8 1 1 3 1
6 PsdA-L5A 2 16 8 8 4 4 3 2 1 0
7 PsdA-S6A 32 8 4 4 2 2 5 0 1 0
8 PsdA-L7A 16 16 16 8 8 4 0 6 0 0
9 PsdA-S8A 4 >32 4 4 2 1 5 0 0 1
10 PsdA-I9A >32 32 >32 8 8 4 0 3 1 2
11 WLIP (PsdA-Q2E) 32 32 >32 16 8 8 0 1 4 1
12 PsdA-V4A/L5A/L7A/I9A >32 >32 >32 >32 >32 >32 0 0 0 6
Acyl chain variations
13 PsdA-C4 >32 >32 >32 >32 32 >32 0 0 0 6
14 PsdA-C6 >32 >32 >32 32 32 16 0 0 0 6
15 PsdA-C8 >32 >32 >32 >32 32 8 0 0 1 5
16 PsdA-C12 8 >32 >32 2 1 1 4 0 0 2
17 PsdA-C14 8 >32 >32 1 1 2 4 0 0 2
18 3S-epi-PsdA 4 8 8 2 4 2 6 0 0 0
19 3-deoxy-PsdA >32 >32 8 1 2 2 4 0 0 2
Ring closure variation
20 PsdA-D-Dap3 >32 >32 >32 32 >32 8 0 0 1 5
21 PsdA-D-Ser3 8 4 8 4 4 4 6 0 0 0
Fold perturbation
22 Viscosinamide 8 8 16 4 4 2 5 1 0 0
23 Viscosinamide L5I >32 >32 >32 >32 >32 16 0 0 0 6
24 PsdA-NMe1d 8 8 8 2 2 1 6 0 0 0
25 PsdA-NMe7d >32 >32 >32 >32 >32 >32 0 0 0 6
Distribution of strain sensitivity to PsdA analogs 3-25c
0.5 ≤ F ≤ 2.0 8 5 8 9 11 10
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by the results of the alanine scan; (2) evaluate the role of
the fatty acid tail by varying the carbon chain length and the
stereochemistry and presence of the 3-hydroxyl functionality
(13–19); (3) establish the importance of the ester bond as ring-
closing linkage by introducing an amide (lactam) instead of the
ester bond (20) and evaluate the influence of a more subtle
replacement of D-aThr3 by a D-Ser (21) – such modifications
have been shown to either increase or abolish activity in other
CLiPs (see below) and; (4) assess the importance of maintaining
the helical fold by introducing a helix disrupting residue (22 vs.
23). As the original synthesis route (Figure 3) was developed
to maximize automation and allow facile substitution of the
amino acids as well as the lipid moiety, our total synthesis route
allowed convenient generation of these 20 novel and non-natural
analogs (Table 1), testifying to the versatility of the designed
synthesis route. The strategy (left branch, Figure 3) relies on
side-chain attachment of the 8th residue to the solid support,
invariable a D-serine in the viscosin group CLiPs, with the
C-terminus protected via an allyl protecting group, thus allowing
to perform an on-resin cyclization in a later stage (Figure 3). For
this we successfully introduced a less conventional serine side-
chain to resin attachment and subsequently elongated the peptide
chain via automated solid phase peptide synthesis protocols,
including the enantioselectively synthesized N-terminal (R)-
3-hydroxydecanoic acid lipid, using the classical Fmoc/tBu
protecting strategy. The synthesis of the fatty acid building
block, allowing easy variation of both the chain length as
well as good control of the stereochemistry, was performed as
previously described (De Vleeschouwer et al., 2014). Next, the
C-terminal amino acid (Alloc-Ile) was coupled manually through
esterification with the D-aThr3 side-chain, thus introducing the
depsi bond. After simultaneous removal of the remaining Alloc
and Allyl protecting groups, the linear peptide was cyclized
through on-resin macrolactamization. After cleavage from the
solid support, the desired CLiP was obtained in a very high crude
purity, further purified using RP-HPLC and characterized by LC-
MS and NMR spectroscopy, relevant details for each compound
are available in the supporting information.
The S8A analog 9 and analog 20, where the ester is replaced by
an amide bond, required an adapted synthesis route that will be
described in further detail here. As the general synthesis approach
relies on the initial attachment of D-serine as future 8th residue,
S8A analog 9 cannot be made following the existing route.
Therefore, we adapted our strategy without losing the convenient
on-resin cyclization step (Figure 3-middle branch) by anchoring
the D-Ser6 side-chain instead. In this fashion, many characteristic
steps of the general pseudodesmin A synthesis scheme can be
maintained. Actually, the same preloaded resin can be used as
starting point, followed by automated peptide elongation and
on-resin esterification with Fmoc-L-Ile. After esterification with
Fmoc-L-Ile, Fmoc-D-Ala8 and then Alloc-L-Leu7 were coupled
manually. Subsequent Allyl/Alloc deprotection and on-resin
cyclization yielded pseudodesmin S8A (9).
For 20, where the ester (depsi) bond is substituted by an
amide, the amine equivalent of D-aThr would be (2R, 3R)-
diaminobutyric acid. However, this building block equipped with
appropriate protecting groups is not commercially available and
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FIGURE 2 | Summary of the chemical modifications with their location shown
on the overall fold of pseudodesmin A (1), together with the impact on
bioactivity derived from the heat map in Table 1 as follows: if the distribution
count of activity factors F where 0.5 ≤ F ≤ 2.0 for a particular compound is at
least 5 (out of 6) the modification is labeled in green as this signifies a
particular modification does not result in any significant activity change; if the
distribution count of relative activity factors has at least 5 times F ≥ 16, the
residue is colored red, as this modification causes a major change in activity.
All modifications shown in orange indicate points of activity modulation in the
fold that are not very significant or do not occur uniformly enough, i.e., they
have a low distribution count value.
requires a multistep synthesis (Schmidt et al., 1992). Instead,
we chose to use 2,3-diaminopropionic acid (Dap) similar to
the previous examples from literature, which, however, implies
the loss of the β-methyl group. Since the D-Ser3 PsdA analog
21 where the β-methyl group is absent, is equally active as
the natural compound 1 (vide infra), our choice for Dap is
justified. An additional difficulty arising from the use of Dap is
that the two amino groups (α and β) needed to be protected
with two different and orthogonal protecting groups (Bionda
et al., 2012) used a 4-methyltrityl (Mtt) protecting group which
is removed with 1% TFA in DCM (Isidro-llobet et al., 2009).
These conditions are, however, not compatible with 2-CTC resin
and would cause premature cleavage from the solid the support.
In the second example the β-amino was protected with an
Alloc group. However, the C-terminal carboxylic acid of Ser8
is Allyl protected, which is not compatible with Alloc-removal.
Therefore, we opted for the use of an 1-(4,4-dimethyl-2,6-
dioxocyclohexylidene)-3-methylbutyl (ivDde) protecting group
which is (quasi-) orthogonal with a Fmoc/tBu/Alloc strategy
and is hydrazine labile (Rohwedder et al., 1998). Noteworthy is
that this new strategy has an additional degree of orthogonality
compared to the original one.
Taking into account the features of the D-Dap(ivDde) building
block, a new synthesis route toward PsdA D-Dap3 analog 20 was
drafted (Figure 3, right branch). The synthesis started from the
same preloaded resin which was elongated in automated fashion
to obtain the linear lipopeptide. After removal of the ivDde
group, the deprotected β-amino group is coupled with Alloc-
L-Ile through the formation of an amide bond. Subsequently,
Alloc and Allyl protecting groups are removed followed by on-
resin cyclization. After the automated synthesis we detected the
formation of an additional cyclic product (the α-amino cyclized
isomer of 20) which resulted from migration of the ivDde
protecting group from the side chain to the alpha-amino group
during Fmoc deprotection following Dde-Dap introduction (see
Supplementary Material) (Wilhelm et al., 2006). However, this
side product was easily separated using RP-HPLC from the
desired compound 20 that was ultimately obtained in a satisfying
yield of 25%, based on the initial loading of the resin (see
Supplementary Material).
Biological Activity and Structure Activity
Relationship
General Considerations
Prior to biological assays, the chemical identity and integrity
of all synthesized PsdA analogs was confirmed by LC-MS and
NMR spectroscopy (Supplementary Material). As conservation
of the PsdA fold is essential in order to correlate structure to
function, significant changes in conformation resulting from
the modification were assessed by monitoring changes in 1H
and 13C chemical shifts and 3JHα HN coupling constants in
CD3CN relative to natural PsdA for each analog (Supplementary
Material). Since the PsdA fold comprises a left-handed α-helix
extending from Leu1 tot D-Ser6, it is accompanied by a
characteristic fingerprint of sequential NHi to NHi+1 nOe cross-
peaks, which was also used to easily check for the preservation of
the PsdA fold. As will be detailed further below, all spectroscopic
information reveals that the conformation of all novel analogs
but one (23, vide infra) is conserved, placing the discussion of
structure-activity relations on a firm basis both in two (structure)
and three (fold) dimensions.
Given that PsdA did not show activity against a selection
of Gram-negative bacteria (Sinnaeve et al., 2009b), a test
panel consisting solely of Gram-positive pathogens was used
to create a benchmark for biological activity against which the
impact of structural modifications was scored. The selection
of six organisms for the panel was not intended to assess the
activity spectrum or strength but aimed to provide a means
to correlate changes in the activity profile to the structural
modifications introduced, while including some representatives
of different clinically relevant genera of Gram-positive bacteria.
Furthermore, antifungal activity against Candida albicans and
Aspergillus fumigatus was also tested but proved absent (data
not shown). All activity tests used a broth microdilution method
(Clinical and laboratory standards Institute [CLSI], 2012) with
12 concentrations ranging from 0.016 to 32 µg/mL in twofold
dilution steps. From previous screens (De Vleeschouwer et al.,
2014), it was already apparent that some of the curves describing
the relationship between CLiP activity (i.e., growth inhibition)
and concentration were not as clear-cut as those observed for
vancomycin and daptomycin (clinically used antibiotics included
Frontiers in Microbiology | www.frontiersin.org 7 April 2020 | Volume 11 | Article 646
fmicb-11-00646 April 21, 2020 Time: 14:19 # 8
De Vleeschouwer et al. Molecular Determinants of Pseudodesmin A Antimicrobial Activity
FIGURE 3 | Synthetic route toward pseudodesmin A and analogs. Left branch: Ala-scan (3–10, 12), WLIP (11), lipid tail (13–19), D-Ser3 (21), viscosinamide (22),
viscosinamide L5I (23), NMe analogs (24–25), and Trp analogs (26–28) – note that the configuration at the 3-hydroxy position is not specified as this branch covers
the synthesis of compounds featuring S and R stereochemistry, respectively. Middle branch: PsdA S8A (9) analog. Right branch: amide cyclized D-Dap3-analog (20).
Reagents and conditions: (a) (i) 20% piperidine, NMP; (ii) Fmoc-AA-OH, HBTU, DIPEA, NMP; (b) Alloc-L-Ile, DIC, pyridine, DMAP, DMF; (c) [Pd(PPh3)4], PhSiH3,
DCM; (d) HATU, HOAt, DIPEA, DMF; (e) 0.1 M HCl in HFIP + 1%TIS; (f) Fmoc-L-Ile-OH, DIC, DMAP, pyridine, DMF; (g) (i) 20% piperidine, NMP (ii) Fmoc-D-Ala-OH,
HBTU, DIPEA, (iii) 20% piperidine, NMP (iv) Alloc-L-Leu-OH, HBTU, DIPEA; (h) 2% hydrazine, allyl alcohol, NMP (following the standard NovaBiochem protocol,
Rohwedder et al., 1998); (i) Alloc-L-Ile-OH, HBTU, DIPEA, and DMF. Full chemical structures for all analogs are collected in an overview table in the Section
“Supplementary Material.”
as controls), but can show a more complicated behavior in
which growth is apparently not completely inhibited at higher
concentrations, thus leading to difficulties in reproducibility
when establishing the MIC value. Therefore, we used the minimal
concentration that inhibited growth by at least 50% compared
to the untreated control (i.e., MIC1/2) instead as it proved
to be a more reliable measure to describe changes in relative
potency over the range of compounds (Table 1), enabling sound
comparative analysis of the analogs’ performance.
To aid in the interpretation we find it useful to introduce a
heat map representation of the values in Table 1, whereby the
color coding reports the factor by which a specific structural
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change has affected the MIC1/2 value relative to natural PsdA,
considered as the reference. In this heat map, MIC1/2 values
identical to the reference are indicated in green, as are relative
changes by a factor of 0.5 or 2 since CLSI guidelines state that a
difference in MIC1/2 value corresponding to one twofold dilution
should not be considered as a relevant difference (Clinical and
laboratory standards Institute [CLSI], 2012). This was the case
for the activity of the synthetic versions of WLIP (11) (De
Vleeschouwer et al., 2016), PsdA (De Vleeschouwer et al., 2014),
and (22) viscosinamide (data not shown) when compared to their
natural counterpart. Significant reductions in activity are color-
coded starting from a factor of 4, coded in yellow, followed by
a factor of 8 in orange, while any change in relative MIC1/2
value by a factor equal to or larger than 16 is coded in red. The
table is completed by a frequency count of these factors, giving a
more quantitative impression of the performance of a particular
compound with respect to the test panel (rows in Table 1)
and the sensitivity of a particular organism against changes in
PsdA structure (columns in Table 1, vide infra). This frequency
count was subsequently also used to provide an overview of how
specific modifications impact on bioactivity (Figure 2). Finally,
as vancomycin and daptomycin were used as controls in all
assays, the relative performance of PsdA with respect to these
antibiotics against the panel of Gram-positive organisms is also
rendered using a heat map, as shown at the bottom of Table 1,
now with the color coding based on vancomycin as reference
substance. While many other factors of course play a role in
determining whether a compound has a potential future as an
antibiotic (toxicity, distribution in the body, stability, . . .) our
data indicate that at least in this in vitro assay PsdA performs
quite adequately when compared to the reference compounds
vancomycin and daptomycin.
The Role of Individual Amino Acids: Alanine Scan
3–10 and Subsequent Analogs 11–12
PsdA analogs 3–10 together constitute the alanine scan of
the PsdA sequence wherein each amino acid is consecutively
substituted by an alanine except for D-alloThr3, for obvious
reasons (Figure 2). Inspection of the NMR spectra and
assignment data (see Supplementary Material) shows very high
similarity in resonance positions for non-substituted amino acid
residues, and additional analysis of the NOESY spectra indicates
that each substitution has conserved the overall structure, thus
allowing assessment of each residue’s contribution to the activity
profile. As is evident from the bioactivity screen in Table 1, no
single amino acid residue appears to be an absolute determinant
for PsdA activity against the test panel. Indeed, no single analog
experiences total loss of detectable activity for all six pathogens.
Nevertheless, some positions appear more sensitive (MIC1/2)
or strain-selective (number and extent of strains affected) than
others. Thus, substitution at the N- or C-terminal position
significantly perturbs activity in all strains. For I9A (10) the
impact on activity is larger than for L1A (3), moving below
detectable levels for two strains. Substitution of D-Val4 (5) has
a similar impact except for S. aureus LMG 10147, where activity
is retained. As is evident from the activity distribution count
in Table 1, the impact of leucine substitutions for alanine at
positions 5 and 7 is less pronounced overall, the relative MIC1/2
increasing fourfold at most. When substituting D-Ser6 (7) for
alanine in between these positions, activity remains unchanged
except for E. faecalis, where it moves close to the detection limit.
A similar observation can be made for S8A (9) which remains
as effective as PsdA in five strains, but displays no detectable
activity against E. faecium. Finally, substitution of D-Gln2 by D-
alanine leads to an interesting analog (4) that has reduced activity
in four strains, with MIC1/2 values above 32 µg/ml for three
strains. However, for both Streptococcus strains, MIC1/2 values
remain unaffected, again indicating strain-specific differences in
susceptibility to the PsdA analogs within the test panel.
It is interesting to note that position 2 represents the spot
where the most notable sequence variation occurs within the
viscosin group. While most other positions show complete
conservation or conservative variations (Figure 1B), position 2
either features a negatively charged D-Glu, like in WLIP(D−)
or a neutral D-Gln as in PsdA (D0). We previously showed
(Geudens et al., 2017) that the activity of natural WLIP(D−) is
attenuated compared to natural PsdA(D0), a result which could
be reproduced here with synthetic WLIP (11) (De Vleeschouwer
et al., 2016) which was not assayed before. It would therefore
appear that the presence of an uncharged but polar side-
chain amide is a trait that confers increased activity against a
majority of strains, as compared to a negatively charged or apolar
side-chain, respectively.
Simultaneous substitution of the hydrophobic side-chains at
positions 1, 4, 7, and 9 by the appropriate D- or L-alanine
in compound 12 fully abolishes the activity. The PsdA fold,
however, is maintained, as indicated by the characteristic string of
sequential nOe’s connecting the amide NH’s from Leu1 to Leu7,
and the excellent 1H chemical shift dispersion, as also observed in
PsdA (Supplementary Material). Even though the amphipathic
organization of this PsdA analog therefore appears preserved, a
strong and overall reduction in activity is observed. Of all analogs
considered it features by far the strongest reduction in overall
hydrophobicity as evident from the reduced HPLC retention
time of 5.4 min compared to 7.4 min for 1 (see Supplementary
Material). This most likely impacts its membrane association and
perturbation potential.
On the Importance of the Lipid Tail 13–19
The carbon chain length of the fatty acid is an important
molecular determinant for activity as immediately apparent from
entries for 13 to 17 in Table 1 and Figure 2. Truncation of the
lipid tail by replacing the (R)-3-HDA with a (R)-3-hydroxylated
butanoic (C4), hexanoic (C6) or octanoic (C8) chain invariably
leads to strong and mostly complete loss of detectable activity
(MIC1/2 ≥ 32 µg/mL) irrespective of the strain tested. In
S. pyogenes the effect is also visible but somewhat more gradual,
increasing in effect from C8 (15) over C6 (14) down to a C4
(13) fatty acid chain. When longer chains are introduced such as
C12 (16) and C14 (17) the effect is less general, but quite binary:
activity is unaffected in four strains, but remains undetectable in
E. faecium LMG 9431 and S. aureus LMG 10197. Not surprisingly,
no chemical shift or conformational changes are apparent from
the NMR spectra of these analogs as only the N-linked fatty acid
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is modified. Therefore, these results unambiguously show that
a minimal carbon chain length exists for the fatty acid moiety
for PsdA to affect Gram-positive bacteria. Also, a decanoic acid
chain length appears optimal as the activity is absent for shorter
chains, while it is reduced to a smaller number of strains when
lengthened. Additional lipid tail analogs 18–19 focus on the
importance of the 3-hydroxyl group which – whenever reported
in literature – always occurs with R stereochemistry in natural
viscosin group members (De Vleeschouwer et al., 2014). As can
be seen from 18, inversion to S does not affect the activity,
whereas its complete removal in the deoxy-PsdA analog 19 again
gives quite a binary effect, strongly impacting two strains while
leaving the other four unaffected.
An Ester Rather Than Amide Cyclization Is Required
for Antimicrobial Activity
This substitution has already been explored for other CLiPs
with mixed results. In the class of fusaricidin analogs from
Bacillus polymyxa, the substitution of D-aThr by D-Dap [(R)-
2-diaminopropionic acid] afforded equally potent analogs with
improved stability and decreased cytotoxicity (Bionda et al.,
2012, 2016), although further analysis indicated that both CLiPs
exhibited a significant difference in their mode of action (Hart
et al., 2014). Daptomycin analogs in which the L-Thr was replaced
by L-Dap have also been made (Hart et al., 2014). This resulted in
a dramatic decrease in antimicrobial activity, which the authors
attribute to conformational changes or restrictions. As mentioned
above, we chose to synthesize the D-Dap3 analog 20, which
should be considered the amide (lactam) analog of a D-Ser3 PsdA
rather than natural PsdA which features a D-aThr3, in order
to avoid synthesis of the non-commercial building block. To
dissect the added impact of the removal of the β-methyl, the D-
Ser3 analog 21 was also synthesized and evaluated. Remarkably,
whereas 21 has identical biological activity as PsdA, indicating
that the loss of the methyl has no impact, complete loss of
detectable activity is observed in five out of six strains for the D-
Dap3 analog 20, activity against the sixth strain being strongly
reduced as well (Figure 2). Inspection of the NOESY spectrum
and comparison to PsdA shows that the overall conformation
is not significantly affected compared to PsdA 1 and the D-
Ser analog 21. Considering that ester bonds are generally more
sensitive to degradation than amide bonds, this observation is
quite remarkable as it indicates that the nature of the ester
functionality itself appears to be an important determinant for
biological activity.
Importance of the Helical Fold for Biological Activity
The main element of the PsdA fold is the N-terminal αL
helix – containing D-amino acid residues – which is stabilized
through ‘stapling’ of the C-terminus (Ile9) halfway onto the
helix (D-aThr3) (Figures 1C, 2). The importance of overall fold
integrity for biological activity of PsdA was already disclosed
in previous work, where an N-methylated PsdA analog with
strongly perturbed fold was reported (De Vleeschouwer et al.,
2017). Here, we chose a more subtle approach aimed at selectively
perturbing the helical fold by exploiting the occurrence of D- and
L-Leu5 homologs in Nature giving rise to D0 and L0 subgroups
(vide supra). Indeed, despite being present in an otherwise all-
D α-helix, an L-Leu5 can populate a small but energetically
allowed ϕϕ, ψ region of the Ramachandran map corresponding
to a left-handed αL conformation (Richardson and Richardson,
1989). As shown before for viscosinamide (L0) (22) the αL-helix
conformation is fully maintained and despite some reshuffling of
the amphipathic interface, identical activity to Psd A (D0) (1)
is observed (Geudens et al., 2014). This is no longer the case,
however, when a β-branched L-amino acid, such as Val or Ile
is introduced in the all-D αL-helix (Figure 2). Now, the side-
chain becomes involved in a steric clash with the backbone and
is no longer compatible with an αL fold. As a result, a disruption
of the helix at this position can be anticipated (Richardson
and Richardson, 1989). To minimize spectral overlap for NMR
analysis, L-Ile rather than L-Val was introduced at position 5,
a D-Val already being present at position 4. The L5I analog
23 was no longer soluble in acetonitrile, requiring the use of
DMF as NMR solvent for mutual comparison, thereby already
indicating considerable change. Compared to viscosinamide (L0)
(22) in DMF, the amide signals appear broadened and the overall
dispersion of the signals is quite different and more convoluted
(Supplementary Material). This strongly suggests a disruption
of the helical fold, now possibly interconverting between multiple
conformations, rather than completely unfolding. The MIC1/2
of 23 indicates a marked and uniform reduction in biological
activity at the same level as that observed when truncating the
fatty acid carbon chain length. This observation is in line with
those reported earlier for N-methylated PsdA analogs, which
were re-assayed here (De Vleeschouwer et al., 2017). While
N-methylation of the Leu1 amide (24) left the activity and
conformation unchanged, N-methylation of Leu7 (25) uniformly
abolished activity, as the structural constraints imposed by the
inwards facing methyl group and the lack of hydrogen-bond
formation potential strongly perturbed and destabilized the
overall fold. Together, our results demonstrate that the α-helix
plays an important role in the stability of the overall fold and
that maintaining its conformation is an absolute prerequisite for
biological activity.
DISCUSSION
Several literature reports have highlighted membrane
permeabilization effects for viscosin group CLiPs, possibly
through pore formation (Coraiola et al., 2006; Lo Cantore et al.,
2006; Reder-Christ et al., 2012). Together with our disclosure
that the mirror-image of PsdA (2) is equally active as the natural
compound (1) (De Vleeschouwer et al., 2014), a mechanism of
action sensitive to chiral interactions, either with a membrane
embedded receptor or with specific lipids (Henriques et al.,
2019) appears highly unlikely. Thus, a better understanding of
how the peptide constitution and three-dimensional structure
combine to interact and perturb the lipid bilayer is an important
key to unravel the mode of action. It is important to realize that
the impact of peptide-membrane interactions depends both on
the local concentration of the active agent in the membrane
(i.e., partitioning) and the magnitude of the perturbation the
Frontiers in Microbiology | www.frontiersin.org 10 April 2020 | Volume 11 | Article 646
fmicb-11-00646 April 21, 2020 Time: 14:19 # 11
De Vleeschouwer et al. Molecular Determinants of Pseudodesmin A Antimicrobial Activity
agent subsequently induces in membrane organization and
function (Heerklotz and Keller, 2013; Fiedler and Heerklotz,
2015). Since both aspects depend on the peptide as well as
on the lipid composition, a straightforward interpretation
of the results obtained here in term of structure-activity
relations, is a challenging undertaking. This is already apparent
from the variation in activity response (MIC1/2 values) from
the Gram-positive organisms in the test panel. Of the six
Gram-positive strains, E. faecalis LMG 8222, E. faecium LMG
9431, and S. aureus LMG 10147 are clearly more sensitive to
structural variations in 3–21 and 23 compared to the other
three strains. Indeed, a count of the number of analogs with
modifications that move the activity close to or above the
detection threshold (i.e., ≥32 µg/mL) occurs in 53% of the
cases for the sensitive strains, a value that halves to 27% for the
less sensitive ones. We propose that this division in sensitivity
between the groups results, at least in part, from differences
in composition of the membrane which is well-known to vary
between species. Since our screening aimed to investigate the
molecular determinants of activity at the level of the peptide,
we used the response of these most sensitive strains to identify
loci of importance for bioactivity, whereas the response recorded
for the less sensitive strains was used to assess its generality
importance. All biological activity results were confronted
with the fold of pseudodesmin A (Figure 4B), complemented
with information obtained using NMR on the location and
orientation of viscosinamide in DPC micelles (Geudens et al.,
2017, 2019). While both CLiPs differ by a D-Leu5 to L-Leu5
switch in stereochemistry, they are equally active. Therefore,
the impact of this naturally occurring configuration switch on
the molecular properties appears limited and therefore of no
consequence when matching the activities of pseudodesmin
analogs with the behavior of viscosinamide when bound to
the membrane.
In DPC/H2O solutions of viscosinamide, the amphipathic
distribution of residues over opposing faces of the viscosin
CLiP fold drives individual molecules to be located near the
phosphocholine head groups of DPC molecules. The α-helix
orients parallel to the lipid/water interface with the center of
mass close to the transition of the polar head-group to the
non-polar lipid chain and the hydrophobic moment pointing
toward the micelle’s core (Geudens et al., 2019). Applying this
orientation to pseudodesmin A (Figure 4A) most hydrophobic
side-chains oriented toward the lipid interior (Figure 4B), while
the polar residues are exposed to the choline head group and
are readily solvent accessible (Figure 4B). In the following, these
two opposite viewpoints are used to map the contributions from
residues to the biological activity on the pseudodesmin A fold.
Not surprisingly, modifications that perturb fold integrity and
the associated amphipathicity also abolish biological activity as
shown before for N-Me-Leu7 PsdA (25) and here now also
for L5I PsdA (23) because it disrupts the amphipathic profile.
In addition, the alanine scan results show that replacing the
branched aliphatic side-chain of (iso-)leucine (3, 8, 10) and
valine (5) residues by a simple methyl reduces the activity rather
uniformly (Figure 4B). The only exception is D-Leu5 (6), which
appears to be a considerably less sensitive position for alanine
substitution, an observation which correlates with the natural
occurrence of D/L variations in viscosin group CLiPs. When all
these hydrophobic residues are replaced by alanine, a cumulative
effect occurs leading to inactivity. This may be caused be a
reduced affinity caused by the reduction in hydrophobic surface,
while maintaining the polar one, or a decreased membrane
perturbation potential resulting from reduced side-chain – lipid
chain interactions. Indeed, the compound needs less space to
‘carve into’ the outer lipid bilayer thereby reducing curvature
stress over the bilayer, for instance. For the polar residues,
only substitution of D-Gln2 causes a marked effect (Figure 4B)
FIGURE 4 | (A) Solution conformation of pseudodesmin A (1) in acetonitrile (Sinnaeve et al., 2009b; Geudens et al., 2014) displaying the helix as a ribbon and
side-chains as indicated. The fatty acid chain is not shown, as it does not adopt a specific conformation. The helix is shown with its main axis oriented horizontally,
an orientation parallel to the water(top)/lipid(bottom) interface as experimentally determined for viscosinamide, the L-Leu5 analog of 1, in DPC micelles. The green
arrow indicates the hydrophobic moment which is quasi perpendicular to the helix and points toward the lipid interior. (B) Solvent accessible surface representation
of pseudodesmin A as seen from a position in the plane of figure (A) either from below (left) or above (right) the helix, thus representing opposing views from either
inside or outside a DPC micelle. Yellow indicates hydrophobic residues of importance for activity, with pink and orange indicating D-Gln2 and the acyl chain truncated
to the C3 atom, respectively. The D-aThr3 featuring the ester bond is shown in pale (salmon) color, while residues of less or no importance for activity are rendered
with a gray color. Note that the gray area forms a rim spanning most of the molecule (see text).
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although less uniformly so when considering the less sensitive
strains. Interestingly, the D-Glu variant (WLIP, 11), which
introduces a negative charge at physiological pH, has an overall
reduced activity. Since bacterial membranes carry an overall
negative surface charge, it appears most likely that this reduces
its partitioning into the lipid bilayer, thus impacting activity.
Nevertheless, the presence of the D-Gln2 amide side-chain
appears important for activity in its own right as evidenced by
the Q2A (4) analog, possibly indicating the need for hydrogen-
bonding interactions with the phospholipid head group. Finally,
the ester bond linkage appears of uniform importance as well,
since replacement by an amide causes loss of activity, an
observation which is harder to rationalize, given the enhanced
chemical stability of the latter. Nevertheless, the positions where
biological activity is most sensitive to modification in both
sensitive and less-sensitive strains, while maintaining the overall
fold, i.e., Leu1, D-Gln2, D-Thr3, Leu7, and Ile9, cluster together
(Figure 4B), indicating that residues on this face of the CLiP
fold are more important for bioactivity. Interestingly, the other
residues form an inert ‘rim’ along the molecular surface. The acyl-
chain, is known to penetrate more deeply into the DPC micelles
while maintaining flexibility (Geudens et al., 2019) and located
in close vicinity to the active face of the molecule. Due to this
flexibility, its orientation is not displayed beyond the (R)-3-OH,
to avoid over-interpretation. Truncation of the acyl chain below
ten carbons (13–15) causes a strong and uniform reduction in
activity, with increasing impact as one moves from eight to four
carbons (13). The impact of acyl chain lengthening (16–18), on
the other hand, is strain specific, as is the configuration (18) and
presence of the 3-OH group (19).
To translate the structure-activity information obtained from
our study into a mode of action more targeted biophysical
investigations are required. Previously, we used FT-IR and
CD spectroscopy to monitor the interaction of viscosin,
viscosinamide, WLIP and pseudodesmin in liposomes (Geudens
et al., 2017). Fluorescence spectroscopy provides a richer source
of information to study peptide-lipid interactions (Ladokhin
et al., 2000; Matos et al., 2010; Amaro et al., 2014) but
requires the presence of a tryptophan residue. Here, we
demonstrate the value of our structure-activity analysis by using
these to develop a Trp-analog of pseudodesmin A showing
minimal impact on its structural and functional behavior, an
absolute prerequisite for meaningful studies. Being an aromatic
hydrophobic residue, aliphatic hydrophobic positions were
considered for substitutions by tryptophan. Considering the
results of the alanine scan, substitution of D-Leu5 appears most
suitable, with substitutions of Leu1 and Leu7 representing more
sensitive alternatives, Val4 and Ile9 not being considered due to
their higher sensitivity to alanine substitution and the presence of
β-branched side-chain. The L1W (26), L5W (27), and L7W (28)
analogs were synthesized, respecting the L/D/L configuration at
these positions. As is evident from Table 1, the biological activity
of the L5W analog remains unaffected for all strains, while L1W
and LW7 show inactivation for one and two strains, respectively,
in good qualitative agreement with expectations. Our results
indicate the validity of these Trp analogs for future investigation
using fluorescence spectroscopy.
CONCLUSION
The specific amphipathic fold of viscosin group CLiPs associated
with the depsipeptide cycle, known from X-ray and NMR
recently shown to be maintained in DPC/water solutions,
together with a minimal acyl chain length which is optimally
composed of ten carbons, represent the essential molecular
determinants for bioactivity of pseudodesmin A, and by
extension, any member of the viscosin group. This is in
excellent agreement with the occurrence of peptide-membrane
interactions as an important primary step in the mode of
action of this group of compounds. Changes at the residue
level reduce activity but few cause uniformly strong effects, with
residues in the area where the N-terminal exocyclic peptide
transitions into the macrocycle, and the lack of a negative
charge appearing most important. These insights, together with
the possibility to introduce modifications, such as tryptophan
residues, for biophysical studies, should pave the way to a
deeper understanding of the mode of action of this group of
compounds known for antimicrobial, plant biocontrol and more
recently antitumor potential (Raaijmakers et al., 2010; Geudens
and Martins, 2018; Götze and Stallforth, 2019).
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